Neurological & Neuromuscular
Also called Friedreich's ataxia, FA, FRDA
Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by GAA trinucleotide repeat expansion in the FXN gene, which encodes frataxin protein. Frataxin is essential for mitochondrial function and iron homeostasis; when deficient, mitochondrial dysfunction and iron accumulation damage neurons and cardiac muscle.
About trials for Friedreich Ataxia
Clinical trials for FRDA are evaluating frataxin gene replacement therapy, frataxin upregulation strategies (like omaveloxolone), mitochondrial function enhancers, and iron chelation approaches. The Friedreich's Ataxia Research Alliance (FARA) maintains comprehensive trial information and patient resources.
Try Match Me →Symptoms typically begin in late childhood to early adulthood (ages 10-25 years). Affects males and females equally. Usually leads to wheelchair dependence within 15-20 years of symptom onset; lifespan reduced by 10-15 years, with cardiac complications the most common cause of death.
Clinical trials for FRDA are evaluating frataxin gene replacement therapy, frataxin upregulation strategies (like omaveloxolone), mitochondrial function enhancers, and iron chelation approaches. The Friedreich's Ataxia Research Alliance (FARA) maintains comprehensive trial information and patient resources. Early diagnosis through genetic testing is important to allow participation in clinical trials that may slow disease progression. Omaveloxolone, a phase 3 trial drug, has shown promise in slowing neurological decline. Genetic counseling is recommended for affected individuals and families. Multidisciplinary care including neurology, cardiology, and rehabilitation services optimizes outcomes and quality of life.
Duchenne muscular dystrophy is an X-linked genetic disorder causing progressive muscle weakness and degeneration, beginn...
Spinal muscular atrophy is an autosomal recessive genetic disorder affecting motor neurons in the spinal cord, causing p...
Myasthenia gravis is a chronic autoimmune neuromuscular disorder causing muscle weakness and rapid fatigue. Antibodies a...